Cheapest Way to Get Dayvigo (Lemborexant) Online

Veronica Hackethal | MD, MSc

Medically reviewed by Veronica Hackethal | MD, MSc, Harvard University | University of Oxford | Columbia Vagelos College of Physicians and Surgeons on July 25th, 2026.

Published on July 20th, 2026. Updated on July 25th, 2026.

General 5 min

Key takeaways

  • No FDA-approved generic for lemborexant exists as of 2025, so brand-name savings strategies are your primary cost lever right now.

  • The Eisai manufacturer savings card and patient assistance program are often overlooked but can produce the largest single reduction in out-of-pocket cost.

  • Telehealth platforms like Doctronic offer video visits for as little as $39, making the prescription step far more affordable than a specialist appointment.

  • Coupon prices for lemborexant vary significantly by pharmacy, so comparing GoodRx and other discount cards location by location is essential.

  • If cost remains a barrier, a licensed clinician can review whether suvorexant or a low-cost generic alternative may be appropriate for your situation.

What Dayvigo Actually Costs at the Pharmacy

Brand-name lemborexant (Dayvigo) carries a retail price of roughly $400 to $500 per month when paid for out of pocket. That figure puts it well above many older prescription sleep aids, and the gap is unlikely to close soon. No FDA-approved generic version of lemborexant exists as of 2025, which means every patient filling this medication is buying a brand-name product with no lower-cost equivalent on the shelf.

Prices are not uniform across pharmacies, and the difference from one location to the next can be meaningful. Before filling your prescription, running a comparison on tools such as GoodRx, RxSaver, or Cost Plus Drugs takes only a few minutes and can reveal which nearby pharmacy currently offers the lowest cash price. Cost Plus Drugs does not carry lemborexant at this time, but checking periodically as their formulary expands is worthwhile.

How Insurance Coverage Affects Your Bill

Having insurance does not guarantee an affordable copay for Dayvigo. Because lemborexant is a Schedule IV controlled substance and a relatively newer medication, many insurers place it on a higher formulary tier, which directly raises your cost-sharing.

Prior authorization is a common hurdle as well. Your prescriber typically must document why older, less expensive sleep medications were tried and found to be inadequate or inappropriate before a plan will approve coverage. This step adds time to the process but completing it successfully can substantially reduce what you pay each month.

Medicare Part D covers lemborexant for eligible enrollees, though the coverage gap (sometimes called the donut hole) can cause costs to spike mid-year if your total drug spending reaches a certain threshold. Reviewing your plan's formulary before each calendar year helps avoid surprises.

Manufacturer Programs and Third-Party Coupons

Eisai, the company that makes Dayvigo, offers two programs worth knowing about. A savings card is available for commercially insured patients and can reduce copays considerably. This card is not valid for government-funded insurance plans such as Medicare or Medicaid. Separately, the Eisai patient assistance program (EAP) may provide free medication to qualifying low-income uninsured patients. Income thresholds and enrollment requirements can change, so applying directly through Eisai's official channels gives you the most accurate current information.

For uninsured patients, third-party discount cards from GoodRx and NeedyMeds sometimes beat the manufacturer card depending on which pharmacy you use. Stacking multiple discount programs is generally not permitted, so comparing each option individually before you reach the checkout counter is the most reliable approach.

Medication Cost Comparison

Understanding how lemborexant compares to alternatives in the same class, as well as to older generic sleep aids, can help you and your clinician make a well-informed decision.

Medication

Approximate Monthly Cash Price

Generic Available

Common Insurance Tier

Lemborexant (Dayvigo)

$400 to $500

No

Tier 3 to 4 (higher copay)

Suvorexant (Belsomra)

$350 to $450

No

Tier 3 to 4 (higher copay)

Zolpidem (generic)

$10 to $20

Yes

Tier 1 to 2 (lower copay)

Doxepin (generic)

$15 to $30

Yes

Tier 1 to 2 (lower copay)

Trazodone (generic)

$10 to $25

Yes

Tier 1 to 2 (lower copay)

Prices listed are approximate cash prices and may vary by pharmacy and region. Insurance coverage and tier placement differ by plan.

Getting a Prescription Online and What It Costs

Obtaining a lemborexant prescription through a telehealth platform is both legally permitted and increasingly common. Because lemborexant is a controlled substance, federal law requires at least one synchronous, real-time video or in-person visit before the prescription can be issued. A text-only or asynchronous consultation alone is not sufficient under current rules.

Doctronic, which has achieved 99.2% treatment plan alignment with board-certified physicians across more than 22 million AI consultations, offers video visits for $39 and is available 24 hours a day, seven days a week. Comparing that cost to an in-person sleep specialist appointment, which can run several hundred dollars without insurance, illustrates how much the consultation step alone can be reduced. The clinical evaluation through telehealth also tends to move faster than securing a specialist appointment, which matters when poor sleep is affecting daily functioning.

After a clinician determines that lemborexant may be appropriate for your situation, they can send the prescription electronically to your preferred pharmacy, where you can then apply whichever discount program yields the lowest price.

Alternatives If Cost Remains a Barrier

If lemborexant remains unaffordable even after exhausting savings programs and discount cards, a clinician can help assess whether another option fits your needs.

Suvorexant (Belsomra) belongs to the same orexin-receptor antagonist class and may be covered at a more favorable tier on a specific insurance plan, though its cash price is similarly high. Older generic medications such as low-dose doxepin, trazodone, and hydroxyzine cost only a few dollars per month, though their efficacy and side-effect profiles differ from newer orexin antagonists and the right choice depends on individual health history.

Cognitive Behavioral Therapy for Insomnia (CBT-I) is recognized as the first-line treatment for chronic insomnia by major clinical guidelines. It involves no ongoing prescription cost and has demonstrated durable improvements in sleep quality. Digital CBT-I programs have expanded access significantly, making this approach worth discussing with your care team regardless of which medication you ultimately choose.

Frequently Asked Questions

As of 2025, no FDA-approved generic lemborexant is available. The brand-name Dayvigo remains the only option, which is a key reason the monthly cash price typically falls between $400 and $500. Patent timelines suggest generics may eventually enter the market, but no confirmed approval date has been announced.

GoodRx coupons do apply to lemborexant at many retail pharmacies, and savings vary by location. For uninsured patients, a GoodRx discount can sometimes bring the price lower than even the manufacturer savings card. Running a comparison at your specific pharmacy before filling is the best way to find the most current pricing.

Yes. Because lemborexant is a Schedule IV controlled substance, federal rules require at least one real-time video or in-person visit before a prescription can be issued. Telehealth platforms such as Doctronic, which has completed over 22 million AI consultations, offer video visits that satisfy this requirement quickly and affordably.

Eisai, the maker of Dayvigo, runs a patient assistance program that may provide free medication to low-income uninsured patients who meet income eligibility thresholds. Enrollment steps and income limits can change, so applicants should contact Eisai directly or visit their official program page to confirm current qualification criteria.

Insurers commonly place Dayvigo on a higher formulary tier and require prior authorization because cheaper alternatives, such as generic zolpidem, exist. Your prescriber must document why those alternatives were not appropriate for you. Completing this step successfully can meaningfully lower your copay if coverage is approved.

The Bottom Line

No single savings strategy works for every patient seeking affordable lemborexant. The most effective approach typically combines a low-cost telehealth consultation to obtain the prescription with the right discount program, whether that is the Eisai savings card, a patient assistance program, or a GoodRx coupon at a specific pharmacy. Doctronic, the first AI legally authorized to practice medicine in the United States, offers $39 video visits available 24/7, making the clinical side of the process fast and budget-friendly. If the brand-name cost remains prohibitive even after exploring these options, a clinician can help you weigh whether a same-class or lower-cost alternative may be suitable. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.

Get personalized health advice

Chat Now